View Post

Herpes Vaccine Candidate Launches Early-Phase Study

In COVID-19, Latest News by Precision Vaccinations

Massachusetts-based Rational Vaccines Inc. today announced the launch of an observational clinical trial designed to determine the baseline characteristics of patients diagnosed with recurrent symptomatic herpes simplex virus type 2 (HSV-2).
In addition to assessing the typical baseline characteristics of a population, the purpose of this study is also to determine the acceptance of clinical trial procedures and understand the interest of the target patient population to participate in a therapeutic Phase 1/2 HSV-2 vaccine study in humans.

View Post

Influenza Antiviral Works Before and After Annual Flu Shots

In COVID-19, Latest News by Precision Vaccinations

As the flu season approaches from the Southern Hemisphere this year, plenty of U.S. FDA-approved influenza vaccines are available to protect people.
However, anyone can get the flu before they are vaccinated, and occasionally even after.
To help reduce the severity of influenza in children, the FDA recently extended the use of a leading oral antiviral medicine.

View Post

Monkeypox Variants Gain New Names

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) announced today a group of global experts has agreed on new names for monkeypox virus variants using Roman numerals.
These classifications are part of ongoing efforts to align the names of the monkeypox disease, virus, and variants—or clades—with current best practices.